Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists

Myelodysplastic syndromes (MDS) arising in the context of inherited bone marrow failure syndromes (IBMFS) differ in terms of prognosis and treatment strategy compared to MDS occurring in the adult population without an inherited genetic predisposition. The main molecular pathways affected in IBMFS i...

Full description

Bibliographic Details
Main Authors: Elena Crisà, Paola Boggione, Maura Nicolosi, Abdurraouf Mokhtar Mahmoud, Wael Al Essa, Bassel Awikeh, Anna Aspesi, Annalisa Andorno, Renzo Boldorini, Irma Dianzani, Gianluca Gaidano, Andrea Patriarca
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/5/2525
_version_ 1797415464088895488
author Elena Crisà
Paola Boggione
Maura Nicolosi
Abdurraouf Mokhtar Mahmoud
Wael Al Essa
Bassel Awikeh
Anna Aspesi
Annalisa Andorno
Renzo Boldorini
Irma Dianzani
Gianluca Gaidano
Andrea Patriarca
author_facet Elena Crisà
Paola Boggione
Maura Nicolosi
Abdurraouf Mokhtar Mahmoud
Wael Al Essa
Bassel Awikeh
Anna Aspesi
Annalisa Andorno
Renzo Boldorini
Irma Dianzani
Gianluca Gaidano
Andrea Patriarca
author_sort Elena Crisà
collection DOAJ
description Myelodysplastic syndromes (MDS) arising in the context of inherited bone marrow failure syndromes (IBMFS) differ in terms of prognosis and treatment strategy compared to MDS occurring in the adult population without an inherited genetic predisposition. The main molecular pathways affected in IBMFS involve telomere maintenance, DNA repair, biogenesis of ribosomes, control of proliferation and others. The increased knowledge on the genes involved in MDS pathogenesis and the wider availability of molecular diagnostic assessment have led to an improvement in the detection of IBMFS genetic predisposition in MDS patients. A punctual recognition of these disorders implies a strict surveillance of the patient in order to detect early signs of progression and promptly offer allogeneic hematopoietic stem cell transplantation, which is the only curative treatment. Moreover, identifying an inherited mutation allows the screening and counseling of family members and directs the choice of donors in case of need for transplantation. Here we provide an overview of the most recent data on MDS with genetic predisposition highlighting the main steps of the diagnostic and therapeutic management. In order to highlight the pitfalls of detecting IBMFS in adults, we report the case of a 27-year-old man affected by MDS with an underlying telomeropathy.
first_indexed 2024-03-09T05:48:59Z
format Article
id doaj.art-3b3b6ef85d5a489cb3eac6fff44f445c
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T05:48:59Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-3b3b6ef85d5a489cb3eac6fff44f445c2023-12-03T12:18:57ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01225252510.3390/ijms22052525Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult HematologistsElena Crisà0Paola Boggione1Maura Nicolosi2Abdurraouf Mokhtar Mahmoud3Wael Al Essa4Bassel Awikeh5Anna Aspesi6Annalisa Andorno7Renzo Boldorini8Irma Dianzani9Gianluca Gaidano10Andrea Patriarca11Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyLaboratory of Genetic Pathology, Division of Pathology, Department of Health Sciences, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Pathology, Department of Health Sciences, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Pathology, Department of Health Sciences, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyLaboratory of Genetic Pathology, Division of Pathology, Department of Health Sciences, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, ItalyMyelodysplastic syndromes (MDS) arising in the context of inherited bone marrow failure syndromes (IBMFS) differ in terms of prognosis and treatment strategy compared to MDS occurring in the adult population without an inherited genetic predisposition. The main molecular pathways affected in IBMFS involve telomere maintenance, DNA repair, biogenesis of ribosomes, control of proliferation and others. The increased knowledge on the genes involved in MDS pathogenesis and the wider availability of molecular diagnostic assessment have led to an improvement in the detection of IBMFS genetic predisposition in MDS patients. A punctual recognition of these disorders implies a strict surveillance of the patient in order to detect early signs of progression and promptly offer allogeneic hematopoietic stem cell transplantation, which is the only curative treatment. Moreover, identifying an inherited mutation allows the screening and counseling of family members and directs the choice of donors in case of need for transplantation. Here we provide an overview of the most recent data on MDS with genetic predisposition highlighting the main steps of the diagnostic and therapeutic management. In order to highlight the pitfalls of detecting IBMFS in adults, we report the case of a 27-year-old man affected by MDS with an underlying telomeropathy.https://www.mdpi.com/1422-0067/22/5/2525genetic predispositionmyelodysplastic syndromesinherited bone marrow failure
spellingShingle Elena Crisà
Paola Boggione
Maura Nicolosi
Abdurraouf Mokhtar Mahmoud
Wael Al Essa
Bassel Awikeh
Anna Aspesi
Annalisa Andorno
Renzo Boldorini
Irma Dianzani
Gianluca Gaidano
Andrea Patriarca
Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
International Journal of Molecular Sciences
genetic predisposition
myelodysplastic syndromes
inherited bone marrow failure
title Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
title_full Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
title_fullStr Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
title_full_unstemmed Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
title_short Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
title_sort genetic predisposition to myelodysplastic syndromes a challenge for adult hematologists
topic genetic predisposition
myelodysplastic syndromes
inherited bone marrow failure
url https://www.mdpi.com/1422-0067/22/5/2525
work_keys_str_mv AT elenacrisa geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT paolaboggione geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT mauranicolosi geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT abdurraoufmokhtarmahmoud geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT waelalessa geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT basselawikeh geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT annaaspesi geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT annalisaandorno geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT renzoboldorini geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT irmadianzani geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT gianlucagaidano geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists
AT andreapatriarca geneticpredispositiontomyelodysplasticsyndromesachallengeforadulthematologists